| Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell … T Feuchtinger, K Opherk, WA Bethge, MS Topp, FR Schuster, ... Blood, The Journal of the American Society of Hematology 116 (20), 4360-4367, 2010 | 535 | 2010 |
| Single-center experience of unrelated and haploidentical stem cell transplantation with TCRαβ and CD19 depletion in children with primary immunodeficiency syndromes D Balashov, A Shcherbina, M Maschan, P Trakhtman, Y Skvortsova, ... Biology of Blood and Marrow Transplantation 21 (11), 1955-1962, 2015 | 183 | 2015 |
| Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study J Donadieu, IA Larabi, M Tardieu, J Visser, C Hutter, E Sieni, N Kabbara, ... Journal of Clinical Oncology 37 (31), 2857, 2019 | 165 | 2019 |
| TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia M Maschan, L Shelikhova, M Ilushina, E Kurnikova, E Boyakova, ... Bone marrow transplantation 51 (5), 668-674, 2016 | 147 | 2016 |
| First report of effective and feasible treatment of multifocal lymphangiomatosis (Gorham–Stout) with bevacizumab in a child TGP Grunewald, L Damke, M Maschan, U Petrova, O Surianinova, ... Annals of oncology 21 (8), 1733-1734, 2010 | 80 | 2010 |
| Risk factors for and the clinical impact of cytomegalovirus and Epstein-Barr virus infections in pediatric recipients of TCR-α/β–and CD19-depleted grafts A Laberko, A Bogoyavlenskaya, L Shelikhova, Z Shekhovtsova, ... Biology of Blood and Marrow Transplantation 23 (3), 483-490, 2017 | 77 | 2017 |
| Low-dose donor memory T-cell infusion after TCR alpha/beta depleted unrelated and haploidentical transplantation: results of a pilot trial M Maschan, S Blagov, L Shelikhova, Z Shekhovtsova, D Balashov, ... Bone marrow transplantation 53 (3), 264-273, 2018 | 66 | 2018 |
| Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita F Fioredda, S Iacobelli, ET Korthof, C Knol, A van Biezen, D Bresters, ... British journal of haematology 183 (1), 110-118, 2018 | 64 | 2018 |
| Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT B Dholaria, BN Savani, M Labopin, L Luznik, A Ruggeri, S Mielke, ... haematologica 105 (1), 47, 2020 | 60 | 2020 |
| Tracking T-cell immune reconstitution after TCRαβ/CD19-depleted hematopoietic cells transplantation in children IV Zvyagin, IZ Mamedov, OV Tatarinova, EA Komech, EE Kurnikova, ... Leukemia 31 (5), 1145-1153, 2017 | 60 | 2017 |
| Prophylactic tocilizumab prior to anti-CD19 CAR-T cell therapy for non-Hodgkin lymphoma PF Caimi, G Pacheco Sanchez, A Sharma, F Otegbeye, N Ahmed, ... Frontiers in immunology 12, 745320, 2021 | 54 | 2021 |
| Mismatched related vs matched unrelated donors in TCRαβ/CD19-depleted HSCT for primary immunodeficiencies A Laberko, E Sultanova, E Gutovskaya, I Shipitsina, L Shelikhova, ... Blood, The Journal of the American Society of Hematology 134 (20), 1755-1763, 2019 | 54 | 2019 |
| A conditioning regimen with plerixafor is safe and improves the outcome of TCRαβ+ and CD19+ cell-depleted stem cell transplantation in patients with Wiskott-Aldrich syndrome D Balashov, A Laberko, A Shcherbina, P Trakhtman, D Abramov, ... Biology of Blood and Marrow Transplantation 24 (7), 1432-1440, 2018 | 52 | 2018 |
| Prospective study of a cohort of Russian Nijmegen breakage syndrome patients demonstrating predictive value of low kappa-deleting recombination excision circle (KREC) numbers … E Deripapa, D Balashov, Y Rodina, A Laberko, N Myakova, NV Davydova, ... Frontiers in Immunology 8, 807, 2017 | 51 | 2017 |
| Efficacy of plerixafor in children with malignant tumors failing to mobilize a sufficient number of hematopoietic progenitors with G-CSF AA Maschan, DN Balashov, EE Kurnikova, PE Trakhtman, EV Boyakova, ... Bone Marrow Transplantation 50 (8), 1089-1091, 2015 | 43 | 2015 |
| Multiple site place-of-care manufactured anti-CD19 CAR-T cells induce high remission rates in B-cell malignancy patients M Maschan, PF Caimi, J Reese-Koc, GP Sanchez, AA Sharma, ... Nature communications 12 (1), 7200, 2021 | 42 | 2021 |
| αβ T cell-depleted haploidentical hematopoietic stem cell transplantation without antithymocyte globulin in children with chemorefractory acute myelogenous leukemia L Shelikhova, M Ilushina, Z Shekhovtsova, D Shasheleva, ... Biology of Blood and Marrow Transplantation 25 (5), e179-e182, 2019 | 35 | 2019 |
| CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study E Jacoby, S Ghorashian, B Vormoor, B De Moerloose, N Bodmer, ... Leukemia 36 (6), 1525-1532, 2022 | 33 | 2022 |
| Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell … E Mikhailova, A Semchenkova, O Illarionova, S Kashpor, V Brilliantova, ... British Journal of Haematology 193 (3), 602-612, 2021 | 31 | 2021 |
| Clinical and genomic heterogeneity of Diamond Blackfan anemia in the Russian Federation NS Smetanina, IV Mersiyanova, MA Kurnikova, GS Ovsyannikova, ... Pediatric blood & cancer 62 (9), 1597-1600, 2015 | 31 | 2015 |
